Petition — Benish v. United States
Supreme Court brief1976
Ask Donna
What actually matters in this document.
Text
MICHAEL RODAK, JR. CLERK |
SUPREME COURT OF THE
UNITED STATES
NO. A-514
TIMOTHY C. BENISH and MICHAEL GAICH
Petitioners
vs.
UNITED STATES
Respondent
PETITION FOR WRIT OF CERTIORARI
TO THE UNITED STATES COURT OF APPEALS
FOR THE THIRD CIRCUIT
Dante G. Bertani
Bertani, Myers & Makoski
Counsel for Petitioners
Room 214
Union Trust Building
Main Street
Greensburg, Pa.
ne | et OE or"
INDEX
TABLE OF CONTENTS
FELT EET OTE TEST eT Oe TTT ETT eTT TT Ee 3
ar RO ee ay 3
EE LI ee 4
Constitutional Provisions, Federal Statutes.......... 4
Rules and Regulations Involved
TERS ARS a le a a ee a 5
i oi a eee eee 6
Allowance of the Writ
ie eb a eee ER eeeneens 18
SEE cé¢tbudcdecdeeendendenabhsdenesssseuece 19
CITATIONS
Cases
Barrett vs. U.S., 322 F. 2d 292 (1963)............... 16
Ferry v. Ramsey, 277 U.S. 88 (S/14/28)............. 13
In Re: Winship, 397 U.S. 358 (1970) ................ 15
Leate ¥. U.5., See UB 6, GITBVEB) wc cc ccccccccces 13
23LEd 2d 57
Malloy v. Hogan, 378 U.S. 1, (6/15/64) ............. 15
12L d 2d 683
Morisette v. U.S., 322 U.S. 246 (1952) .............. 12
Morrison v. California, 291 U.S. 82 (1934)........... 13
Spevak v. Klein, 385 U.S. 511 (1967) ............... 15
ee Ge ee es SP FD occ ccccceccecensss 13
87 LEd 1519
Turner v. U.S., 396 U.S. 398 (1/20/70) ............. 13
24 L Ed 2 610
U.S. v. Fabsiazio, 193 F. Supp. 446... ........00008: 12
(Third Circuit, 1961)
kee RG errs 8
U.S. v. Giordano, 15 CRL 3033 (5/13/74)............ 17
U.S. v. Margraf 483 F. 2d 708 (1973)
Western & Alt. Ry. v. Henderson
279 U.S. 639 (1929)
FEDERAL STATUTES, RULES
AND REGULATIONS
Statutes
Comprehensive Drug Abuse and ..... tkeceneunans
Controi Act of 1970
Title 21 U.S.C.
Sec.
Sec
Sec.
Sec.
Sec.
SS ee Cee @ 8 @2@OCe 6.2 eeee ease @e eee ses oes ees eae eS a
Reorganization Plan No. 1 of 1968..................
Title 28 U.S.C.
Sec. 510
Sec. 1
SeCeeeeeeeese Cee aeseesee eoeegseeaeeCce ese ene ee 68 8 6.8 6 a
Pee eee |Cage 6s 62eae 6 eoeeeoee es Cee 80 Cana e © 0 6 6 eo
SBSeeegcse ee eee se ease 6 6
IN THE SUPREME COURT OF THE UNITED STATES
No. A-514
TIMOTHY C. BENISH and
MICHAEL GAICH
Petitioners
VS.
UNITED STATES
Respondent
PETITION FOR WRIT OF CERTIORARI
TO THE UNITED STATES COURT OF APPEALS
FOR THE THIRD CIRCUIT
Timothy C. Benish and Michael Gaich, petitioners pray
that a writ of certiorari issue to review the judgement of
the United States Court of Appeals for the Third Circuit,
centered in their respective cases, tried and reviewed
together and involving identical questions, entered in
this case October 15, 1975S affirming the judgement of
the United States District Court for the Western District
of Pennsylvania entered February 27, 1975.
OPINIONS BELOW
The opinions of the Court of Appeals and District Court
are not yet officially reported.
The opinions are reprinted in Appendix A & B.
JURISDICTION
The judgment of the Court of Appeals was entered on
3
October 15, 1975. On December 5, 1975, Mr. Justice
William J. Brennan, Jr., extended the time within which
to file a Petition for Writ of Certiorari to December 14,
1975. This Court has jurisdiction to review the judgment
by Writ of Certiorari pursuant to authority under 28
U.S.C. sec. 1254 (1).
QUESTIONS PRESENTED FOR REVIEW
I. Whether the procedure provided to establish a
substance as a dangerous drug violates the Constitu-
tional right of due process under the Fifth Amendment
to the Constitution of the United States?
Il. Whether the lack of effective notice of the addition of
a drug to a schedule as a controlled substance negates
the possibility of the defendants formulating a specific
intent necessary to perform an illegal act in violation of
the law?
Ill. Whether it is incumbent upon the Government to
prove the non-existence of excepting circumstances in its
case in chief where there is evidence brought forward
that the defendants may be excepted from the statute?
IV. Whether by the failure of the defendants to present
evidence of an appropriate registration or order form,
they can be presumed not to be holders of a registration
r order form?
V. Whether the establishing of phendimetrazine as a
Schedule III substance was done legally prusuant to
proper legislative authority?
CONSTITUTIONAL PROVISIONS, STATUTES
FEDERAL RULES AND REGULATIONS INVOLVED.
Constitutional Provision Involved:
The due process clause of the fifth
Amendment to the United States
Constitution
Statutes involved:
(1) Comprehensive Drug Abuse
and Control Act of 1970 Title 21
U.S.C. sec. 822 (a), 841 (a) (1),
885, 201, 811 (a) (d) (e) and 871.
(3) Reorganization Plan No. 1 of
1968, Title 28 U.S.C. secs. 509,
510.
Rules and Regulations Involved:
The Federal Register, Volume 38 No. 115. These
provisions are set forth in Appendix C attached hereto.
STATEMENT
Petitioners, Timothy C. Benish and Michael Gaich,
were charged with violations of the Comprehensive Drug
Abuse and Control Act of 1970 (21 U.S.C. sec. 841 (a) 1),
knowingly and intentionally *** dispensing a controlled
substance, and 18 U.S.C. sec. 2 as principal in each
allegation) on two separate occasions; on Court I alleged
to have occurred on July 25, 1973; your petitioners were
acquited; on Count Il (the subject of this Petition)
petitioners were charged with distributing, in August 1,
1973, 9,886 capsules of ‘‘Phendimetrazine a Schedule III
controlled substance, and petitioners were found guilty
of that charge after a non jury trial on June 27, 1974
before the Honorable Judge Edward Dumbald in the
United States District Court for the Western District of
Pennsylvania’”’
Motion for New Trial and/or Arrest of Judgment with
supporting Memorandum of Law on behalf of defendant
S
was timely filed. On February 27, 1975S the Trial Judge
denied and overrules defendant’s Motions and defen-
dant was directed to present himself for sentencing.
Both Petitioners, Timothy C. Benish and Michael
Gaich, were sentenced on April 29, 1975 to make 1/3
restitution of $12.00, pay a fine of $500.00 and be placed
on Probation for 2 years.
Petitioners timely appealed their convictions to the
United States Court of Appeals for the Third Circuit and
after argument on October 15, 1975 before a panel of
that Court, that Court affirmed the judgment of the
District Court:
Petitioners file this petition and request certiorari from
that order.
REASONS RELIED ON
FOR THE ALLOWANCE OF THE WRIT
The question most vital and compelling which the
petitioners raise in the present case goes to the very
heart of a system which cannot be permitted to grow so
huge and so distant from its people as to enact criminal
laws which effect its citizen's life and liberty without fair
and reasonable notice of what laws its citizens in the
future shall be compelled to obey.
This case squarely faces the issue can a government of,
for and by the people, establish a criminal liability upon
its citizens without due process of law. Can a drug be
added to that list of controlled substances under the
Comprehensive Drug Abuse and Control Act of 1970 on
June 15, 1973 with provision that permits registration of
any person who ‘‘manufactures, distributes, dispenses
***or who proposes to engage in the manufacture,
distribution, dispensing*+** of any of those substances,”’
6
on or before August 1, 1973, and then prosecute one who
has allegedly dispensed the substance on August 1,
1973, and at the same time impose criminal liability after
the date of June 15, 1973, except for any person who is
eutitled to register under the registration section. It
appears clearly the provisions of the regulation are
contradictory on its face and without question violative of
petitioners right to due process of law.
It is illogical, unjust, unfair, incomprehensible and
unconstitutional to presume that any citizen of the
United States of America can be subject to the whim and
fancy of the Director of the Bureau of Narcotics and
Dangerous Drugs whomever he may be and whatever
may be his personal prejudices or biases without a
reasonable intelligent effective notice as to what is being
designated as an illegal act. There is no difficulty
understanding that certain acts of man, are in violation
of his fellow mans right to life liberty and the pursuit of
happiness and may be designated as criminal offenses.
Any sensible, reasoning man knows to covet they
neighbors wife or goods or to kill thy neighbor is a crime.
But does every sensible reasoning man know that
phendimetrazine, benzphetamine, chlorphentermine,
diethylpropion, or trinitrotoluene are dangerous drugs
subjecting them to prosecution for possession or
delivery. Does notice in the Federal Register distributed
to special interest groups but not to the average citizen
give proper notice to warn the average citizen of its
message. I think not. For trinitrotoluene is not a listed
controlled substance but TNT. It is well established that
everyone is entitled to due process of law under the Fifth
Amendment but under the present practice of establish-
ing a controlled substance no one is afforded that right.
As ably put by Lord Coke and carved in the Granite of
the rotunda of the University of Pennsylvania, ‘‘The
Knowe Certaintie of the Law is the Safetie of All.”’
-
Knowledge of participation in an illegal transaction is
an essential element of an offense. In the present case
the burden was on the Government to prove the
defendants knowingly violated the law by delivering an
item knowing that it was in violation of the law to deliver
that item, as in United States v. Freed, 401 U.S. 91 St.
Ct. 1112 (1971) where the defendant was charged with
possession of an unregistered firearm by reason of
possession of unregistered hand grenades in violation of
26 U.S.C. 5812, although the statute there contains no
express intent requirement, the Court held, to convict,
the Government must prove knowing possession cf the
item and also knowledge that the item possessed were
hand grenades. In the present case the Government
never proved the items (phendimetrazine) were in fact
known to be phendimetrazine, a controlled substance.
Under the reasoning of the Freed case the Government
must prove defendant knew it to be a deadly weapon (in
the present case a controlled substance) this is
particularly applicable where as in United States v.
Margraf 483 F. 2d 708 (1973), the item is a pocket knife
and has a legitimate use and in the present case, where
as stated in the Federal Register Volume 38 the item is a
drug with a legal medical use and even more applicable
than in the Freed case because the criminal sanctions
section of the Act, Sec. 841 specifically requires
knowledge and intent; Sec. 841 states:
(a) Except as authorized by this
title, it shall be unlawful for any
person knowingly and inten-
tionally ***
(1) To manufacture, distribute or
dispense a controlled substance
(emphasis supplied).
The government failed to prove specific knowledge and
intent.
8
Petitioners - defendants contend that at the time of the
alleged distributions the federal regulation explicitly
permitted their alleged conduct. ;
Sec. 822 (a) of Title 21, U.S.C., the Comprehensive
Drug Abuse and Control Act of 1970, required the
registration of individuals manufacturing, distributing,
or dispensing drugs.
(a) Every person who manufactures, distributes,
or dispenses any controlled substance or who
proposes to engage in the manufacture,
distribution, or dispensing of any controlled
substance, shall obtain annually a registration
issued by the Attorney General in accordance
with the rules and regulations promulgated
by him. (emphasis added).
Failure to register subjects one to the criminal
sanctions of Sec. 841 of Title 21 U.S.C.
(a) Except as authorized by this title, it shall be
unlawful for any person knowingly and
intentionally -
(1) to manufacture, distribute, or dispense a
controlled substance. (emphasis added).
On May 9, 1973, in Volume 38, No. 89 of the Federal
Register, John E. Ingersoll, the Director of the Bureau of
Narcotics and Dangerous Drugs proposed regulations to
control phendimetrazine as a schedule III substance
pursuant to the authority of Sec. 822 (a) of Title 21,
U.S.C. On June 15, 1973, Mr. Ingersoll in Volume 38,
No. 11S of the Federal Register published his
determination to place phendimetrazine in Schedule III.
The effect of Mr. Ingersoll’s action was to make
phendimetrazine a controlled substance and thus made
activity conducted in regards to this drug subject to
possible criminal penalties. Before this date, phen-
dimetrazine was not a controlled substance and thus not
9
illegal to possess or distribute under the controlled
Substance Act Sec. 841 (a) (1), the regulation also gave
notice of the effective date of the enactment of the
regulation.
The requirement imposed upon the anoretic suustances
controlled by this order shall become effective as
follows:
1. Registration - Unless currently registered to
conduct that activity with Schedule III (or, in
the case of fenfluramine, Schedule IV) non
narcotic substances, or unless exempted from
registration by law, or pursuant to 301.24-
301.28 or 311.24-311.28 of Title 21 of the Code
of Federal Regulations, any person who
manufactures, distributes, dispenses, im-
ports, or exports benzphetamine, chlorphen-
termine, clotermine, fenfluramnne, mazindol,
and phendimetrazine, or who proposes to
engage in the manufacture, distribution, dis-
pensing, importation or exportation of any of
those substances, shall obtain a registration to
conduct that activity on or before August 1,
1973.
8. Criminal Liability - Any activity with ben-
zphetamine, chlorophentimine, clotermine,
fenfluramine, not authorized by, or in violation
of, the Controlled Substance Act or the
Controlled Substance Import and Export Act,
conducted after June 15, 1973, except that any
person who is not now registered to handle
these substances but who is entitled to
registration under those acts may continue to-
conduct normal business or professional
practice with those substances between the
date on which this order is published and the
date on which he obtains the proper registra-
tion. (emphasis supplied)
10
9. Other -In all other respects this order is
effective on June 15, 1973.
The regulation makes two substantial changes. For any
person who manufactures, dispenses, or distributes, or
who proposes to do so must register on or by August 1,
1973. Furthermore, any person who is not now
registered but who is entitled to register to handle these
substances may continue to conduct bus: -ss until he
obtains the proper registration.
From this regulation the petitioners submit two
contentions. First: the regulation expressly permits
anyone distributing these controlled substances or
proposing to distribute them to obtain a registration to
conduct such activity on or before August 1, 1973.
Second: Petitioners still had the express legal right to
obtain a registration, as of the date of their arrest or
discontinue any distribution of the controlled substance
after the registration deadline August 1, 1973.
Petitioners by an administrative decision on the part of
the Director of the Bureau of Narcotics and Dangerous
Drugs were excluded from the sanctions of the statute
until August 1, 1973. It is not a question of whether the
petitioners possess an exemption or exception and have
failed to demonstrate such an exemption. Rather the
statute is simply not applicable to them until after
August 1, 1973.
Additionally the petitioners contend that the govern-
ment failed to prove every element of the offense in
another aspect. Sec. 8 of the Effective Dates portion of
the regulations permits any person entitled to be
registered under the Act but not now registered to
continue in the normal cause of business until the proper
registration is obtained. Therefore the petitioners argue
that since no evidence to negate the fact that they are
entitled to register under the Act and therefore entitled
11
to continue to handle these substances, the Government
failed to meet its burden of proof.
Once evidence was adduced before the Trial Court
concerning the July 25, and August 1, 1973 dates, the
issue was raised in the petitioners behalf that they come
within the express permission of the regulations either to
obtain an appropriate registration or to continue to
handle the drug until the registration was obtained as
pointed out in United States v. Fabrizzio, 193 F. Supp.
446 (1961):
*** When evidence appears which tends to bring
the defendant within an exception, ***the burden
is upon the prosecution, on the whole case, to
overcome that evidence beyond a reasonable
doubt.
Petitioners argue that once the issue was raised that
circumstances existed which may except them from the
acts santions, it was incumbent on the government to
negative those excepting circumstances by showing an
intent not to obtain a registration or the fact that they
were not entitled to obtain a registration. No
presumption can be assumed by the Court that because
of a controlled substance, petitioners were not in fact
intending to obey the law. Such a presumption wouid
conflict with the overriding presumption of innocence
with which the law endows the accused and which
extends to every element of the crime, Morisette v.
United States, 322 U.S. 246, (1952).
IV
The very concept that petitioners can be presumed not
to be holders of a registration form flies in the face of the _
constitutional presumption of innocence, and presumes
an illegal act rather than petitioners constitutional right
to a presumption of a lega! act and conduct innocent
within the law and the confines of the Act.
12
Sec. 885 of Title 21, U.S.C. provides that the failure of
an accused to demonstrate that he possesses a proper
registration order form shall cause a presumption to
arise that the accused possessed no proper registration
or order form.
(b) In the absence of proof that a person is the
duly authorized holder of an appropriate
registration order form issued under this
subchapter, he shall be presumed not to be
the holder of such registration or form, and
the burden of going forward with evidence
with respect to such registration or form shall
be upon him.
The existence of a presumption in a criminal prosecu-
tion has been subject to various constitutional tests. In
Ferry v. Ramsey, 277 U.S. 88 the Court there created the
“greater includes the lesser’ test. If the legislature
could act to make the act itself a crime, then the
legislature could make the proof of the act presumptive
proof of an element of an offense. A second test
developed in Morrison v. California 291 U.S. 82 (1934)
held that based on the showing that a fact was more
convenient for the prosecution or for the defense to
produce, a statutory presumption could be placed on the
party for whom the production of such fact was more
convenient. Tot v. United States, 319 U.S. 463,
however, placed constitutional limitations upon both
these tests.
Furthermore, the more recent decisions of Leary v.
United States, 395, U.S. 6, and Turner v. United States,
396 U.S. 398, have completely overturned the former
standards for determining the constitutional validity of a
criminal presumption.
In the instant case the petitioners submit that proof of
the distribution of phendimetrazine cannot constitu-
13
tionally cause a presumption to arise so that it can be
said with substantial assurance that it is more likely than
not that the distributor is not the holder of the
appropriate registration or order form.
Petitioners contend the probable inference is that a
distributor of phendimetrazine would have the proper
registration, since it had medically accepted uses. The
Federal Register, Volume 38, No. 115 publishes the
conclusions of the Secretary of Health, Education, and
Welfare and the Director of the Bureau of Narcotics and
Dangerous Drugs concerning phendimetrazine.
The Director has concluded from his review of
the current situation that control of anorectic
including phendimetrazine, is desirable, at this
time to insure that they will not become widely
abused.
The Ayerst Laboratories has fully cooperated
with the Bureau and has consented to the place-
ment of phendimetrazine in Schedule III to insure
that it does not become subject to abuse in the
future. (emphasis added).
Thus the information now available in that phend-
imetrazine is not now known to be abused.
The Government's own chemist testified to the use of
phendimetrazine as a means to control weight.
Unlike the possession of marijuana or strictly halluc-
inogenic drugs for which there is no medical use and no
justification for possession except for infrequent
instances of scientific investigation, phendimetrazine
does have an accepted use.
Clearly then the real fact is that the distributor of
phendimetrazine is generally done in a legally accept-
able fashion. It is a drug not widely abused, and
therefore it must be presumed to be distributed for
medical reasons and not in violation of the law.
14
The presumption of Sec. 885 fails to pass constitutional
muster in other respects. the statute first causes the
presumption to arise not by proof but by the absence of
proof.’’ ‘‘In the absence of proof (a person)...shall be
presumed not to be the holder of such registration or
order form.’’ Thus the statute shifts the burden to the
petitioners to produce evidence and causes a presump-
tion to arise where the petitioners fail to present a
defense. The defendants argue that the presumption of
Sec. 885 violates their right not to incriminate them-
selves and their constituticnal right to due process.
Untess petitioners prepare a defense and explain their
legal right to a registration or order form, they suffer a
legal penalty. The penalty consists of a jury instruction
they are presumed not to be holder of the appropriate
registration or order form. This directly violates the rule
of Malloy v. Hogan, 378 U.S. 1, that the Fifth
Amendment guarantees that ‘‘the right of a person to
remain silent unless he chooses to speak in the
unfettered exercise of his own will and to suffer no pen-
alty...for his silence.’’ Spevak v. Klein, 385 U.S. 511
(1967) and Garrity v. New Jersey explained the penalty
consists of the “‘imposition of any sanction which makes
the assertion of the Fifth Amendment privilege
‘‘costly’’. ‘‘In the instant case the petitioners silence
causes them to be presumed to lack the proper regist-
ration and virtually assures their conviction.
The presumption of Sec. 885 also violates the consti-
tutional due process of petitioner by shifting the burden
of proof to the petitioners and effectively destroying
their presumption of innocence. Western and Atl. Ry v.
Henderson 279 U.S. 639 (1929). In re Winship, 397 U.S.
358, (1970). held, ‘‘that the Due Process Clause protests
the accused against conviction except upon proof beyond
a reasonable doubt of every fact necessary to constitute
1S
the crime with which he is charged.’’ The (reasonable
doubt) standard provides concrete and substance for the
presumption of innocence, the bedrock axiomatic and
elementary principle whose enforcement lies at the
foundation of the administration of justice.”’
The presumption of innocence means that the defend-
ant cannot be required to take any affirmative action to
defend himself. Despite all the prosecution’s evidence,
he is entitled to do nothing in his own defense. As noted
by Judge Wisdom in Barrett v. United States, 322 F. 2d
292 (1963).
A person accused of a crime has more than the
right to present evidence. He has the consti-
tutional right to sit on his hands 322 F. 2d at 296.
In a criminal prosecution, non-action of the
defendant cannot be substituted for action upon
the part of the state’s case. Neither the burden of
proof nor the burden of proceeding with any
evidence to prove such case can be imposed upon
upon a party charged with a crime. Judge
Peaslee in State v. Lapointe, 81 N.H. 227, 123 A.
692, 696, 31 A.L.R. 1212 (1924).
Sec. 885 of Title 21, U.S.C. clearly violates ‘‘the un-
questioned policy of the criminal law...”’ that the burden
of proving beyond a reasonable doubt all facts necessary
to the defendants guilt’’ is upon the prosecution and not
one iota of burden is upon the defendant.
Vv
Did the Congress of the United States in enacting Sec.
201 (a) of the Comprehensive Drug Abuse Prevention
and Control Act of 1970 wherein it specifically delegated.
authority to the Attorney General of the United States to
place drugs on the controlled drug schedules intend that
authority to be exercised by anyone else or was its
language specific enough to evidence a desire that only
the Attorney General may add to the schedules of con-
16
trolled substances, as stated in the Act, at Section 811
(a), ‘‘The Attorney General shall***. Except as providec
in subactions (d) and (e) of this Section, The Attorney
General may by rule
(1) add te such a schedule or transfer between
such schedules any drugs or substance**s.
(emphasis supplied).
It is particularly enlightening to read this specific
delegation of authority since it was enacted after Sec.
871 of Title 21 U.S.C. and after Sec. 510 of Title 28
U.S.C. and after the Reorganization Plan No. 1 of 1968
(28 U.S.C. Sec. 509) which the Government contends
vested The Attorney General to delegate his authority to
‘any officer, employee, or agency of the Department of
Justice***, Can it be the Governments contention that
the Attorney General was even authorized to delegate,
this authority which Congress specificaily gave only to
him under the Act, to a janitor an employee of the
Department of Justice. The Supreme Court specifically
held in an analygous csituation in United States v.
Giordano, 15 CRL 3033 8/13/74) that notwithstanding a
section of the law giving general delegating authority, 28
U.S.C. Sec. 510 which authorized the Attorney General
to delegate his functions to any other officer, employee
or agency of the Justice Department that Section
2516 (1), dealing with wiretapping, fairly read, was
intended to limit the power to authorize wiretap applica-
tions to the Attorney General himself and to any
Assistant Attorney General.
It seems clear that in the instant case that a
Comprehensive Act designed to control drugs the
Congress was again limiting the Attorney Generals
delegative authority. The Court in Giordano held the
Governments argument that the general delegative
authority was sufficient to permit the Attorney General
17
to delegate his authority in that matter unexceptable and
went on to say that despite such a general delegative
section ‘Congress does not always contemplate that the
duties assigned to the Attorney General may be freely
delegated.”’
Congress could be no clearer than in the case at bar, it
gave that authority specifically to the Attorney General,
therefore the drug phendimetrazine was never legally
and properly established as a controlled substance.
CONCLUSION
For aii the foregoing reasons and primarily to prevent
the further and continued violation of every citizens right
to due process of law, so that every citizen may be
properly advised of the ‘‘known certaintie of the law,’’
this petition for a Writ of Certiorari should be granted.
Respectfully submitted
ut. Ste
DANTE G. BERTANI
Counsel for Petitioners
18
APPENDIX A
UNITED STATES COURT OF APPEALS
FOR THE THIRD CIRCUIT
Nos. 75-1578/1579
UNITED STATES OF AMERICA
Vv,
TIMOTHY C. BENISH
ROBERT H. SISCO
MICHAEL GAICH
TIMOTHY C. BENISH, Appellant in No. 75-1578
MICHAEL GAICH, Appellant in No. 75-1579
Appeal from the United States District Court
for the Western District of Pennsylvania
(District Court Criminal Action No. 73-280)
Argued October 15, 1975
Before: ALDISERT, FORMAN and ADAMS,
Circuit Judges.
JUDGMENT ORDER
After considering the contentions raised by appellants,
to-wit, that the court erred: (1) in that the Government
failed to prove the non-existence of excepting circum-
stances in its case in chief whete there is evidence
brought forward that the appellants may be excepted
from the statute; (2) in presuming that appellants were
not holders of an appropriate registration or order form;
(3) in permitting establishing of phendimetrazine as a
Schedule III substance without proper legislative
19
authority; (4) in permitting a conviction when the
Government failed to prove every essential element of its
case against the appellants; (5) in permitting a
conviction in the face of lack of effective notice of the
addition of a drug to a schedule as a controlled substance
which negated the possibility of the appellants for-
mulating a specific intent necessary to perform an illegal
act in violation of the law and (6) in permitting a con-
viction in the face of a procedure provided to establish a
substance as a dangerous controlled drug contended to
violate appellants’ right to due process under the Fifth
Amendment to the Constitution of the United States; it is
ADJUDGED AND ORDERED that the judgment of the
district court be and is hereby affirmed.
BY THE COURT
/s/ Aldisert
Circuit Judge
Attest:
/s/ Thomas F. Quinn
Thomas F. Quinn, Clerk
DATED: Oct. 15, 1975
Certified as a true copy and issued in lieu
of a formal mandate on November 6, 1975.
Test: Thomas F. Quinn
Clerk, United States Court of Appeals
for the Third Circuit
20
n>
APPENDIX B
IN THE UNITED STATES DISTRICT COURT
FOR THE WESTERN DISTRICT OF PENNSYLVANIA
UNITED STATES OF AMERICA
Plaintiff,
Criminal No. 73-280
Vv
TIMOTHY C. BENISH and
MICHAEL GAICH
Defendants.
OPINION
Dumbauld, J.
Defendants, following a non-jury trial, were con-
victed of the charges contained in Count 2 of the Indict-
ment (but acquitted under Count 1, relating to trans-
actions on a different date). Count 2 charged violation of
21 U.S.C. 841 (a) (1) on or about August 1, 1973, in that
defendants distributed 9,886 capsules of ‘*‘Phendime-
trazine, a Schedule III controlled substance.’’ Motions
in arrest of judgment, or for new trial, are pending.
The so-called ‘‘Comprehensive Drug Abuse Pre-
vention and Control Act of 1970’’ established five classes
of ‘controlled substances.’’ Schedule III included drugs
having less ‘‘potential for abuse’ than those specified in
Schedules I and II. 21 U.S.C. 812 (c) established an in-
itial list of Schedule III drugs, and by 21 U.S.C. 811(a)
the Attorney General was empowered “‘by rule’’ to add
to any Schedule ‘‘any drug or other substance’’ if he
finds ‘‘that such drug or other substance has a potential
for abuse.’’ Such ‘‘rules’’ must be formulated pursuant
to the rulemaking procedures of the Administrative
21
Procedure Act (5 U.S.C. 551 et seg.) which require due
notice, hearing, and the like (5 U.S.C. 553).
Defendants contend that the Attorney General must
act personally in order to add a new substance, such as
phendimetrazine, to Schedule III, relying upon U.S. v.
GIORDANO, 416 U.S. 50S, 510, 513-16 (1974). At the
request of the Court this issue was briefed by the
parties.
However, we are confirmed in our initial impression
that GIORDANO is inapplicable here. That case related
to the authorization of wire-tapping, which is commonly~
regarded as an improper ‘‘dirty business’’ except under
unusual conditions. Accordingly Congress insisted that
such activities be engaged in only pursuant to ‘‘the
mature judgment of a particular, responsible Depart-
ment of Justice official.’’ Hence 18 U.S.C. 2516
specified that authority to permit wire-taps should be
vested in a smail circle of specifically enumerated
officials, namely ‘‘the Attorney General, or any Assis-
tant Attorney General specially designated by the
Attorney General.’’
In the case at bar, however, we do not confront a
situation involving delicate policy issues of law enforce-
ment. We face a technical chemical problem. It would
truly be incongruous to trust the personal professional
opinion of any lawyer on such a question’rather than the
judgment of a qualified hearing examiner in a unit estab-
lished to deal with such technical questions. This is
especially true when the action must be taken ‘‘by rule”’
under the requirements of the Administrative Procedure
Act. It would be strange if Congress had meant to
1 Either immoral, illegal, or unconstitutional, as the case may be.
See OLMSTEAD v. U.S., 277 U.S. 438, 470 (1928); IN RE
MARCUS, 491 F. 2d 901, 903-904 (C.A. 1, 1974); KATZ v. U.S.
389 U.S. 347, 353 (1967).
22
-
require a Cabinet officer to devote his days to protracted
hearings on technical questions, such as the proper
amount of peanuts to be included as an ingredient of
peanut butter? or the potentiality for abuse of particular
varieties of drugs (or even their safety or efficacy).
We therefore conclude that phendimentrazine is
indeed a Schedule III controlled substance. It became
such on June 15, 1973, pursuant to an order, dated June
12, 1973, signed by John E. Ingersoll, Director of the
Bureau of Narcotics and Dangerous Drugs in the Depart-
ment of Justice‘ and published in the Federal Register of
June 15, 1973 (Vol. 38 No. 115, pp. 18719-22).
Paragraph | of the provisions in the order of June 15,
1973, regarding effective dates, required persons
distributing or proposing to distribute phendimentrazine
to ‘‘obtain a registration to conduct that activity on or be-
fore August 1, 1973.”’
Paragraph 8 subjected to criminal liability any
activity with said drug not authorized by, or in violation
of, the Act of 1970, occuring after June 15, 1973, except
that any person not registered ‘‘but who is entitled to
registration ‘‘may’’ continue to conduct normal business
or professional practice with those substances between
the date on which this order is published and the date on
which he obtains the proper registration.”’
2 Although judges must decide patent cases. See Henry J.
Friendly, FEDERAi JURISDICTION: A GENERAL VIEW
(1973) 156-57.
3 Joseph C. Goulden, THE SUPERLAWYERS (1972) 186-87;
Richard A. Merrill and Earl M. Collier, Jr., ‘‘Like Mother Used
to Make’’: An Analysis of FDA Food Standards of Identity,’’ 74
Col. L.R. (May, 1974) 561, 585-91; CORN PRODUCTS CO. v.
DEPT. OF H.E.W., 427 F. 2d Sil (C.A. 3, 1970). The
administrative proceedings began in 1959 and ended in 1968.
23
Defendants contend that this ‘‘grandfather clause’
made their dealings in phendimetrazine legal up until
August 1, 1973.
Disregarding complexities regarding computation of
time it suffices to point out that the Indictment alleges
that the offense occurred on or about August 1, 1973,
and that the regulation required registration ‘‘on or
before August 1, 1973."’ There is no evidence in the
record either that defendants had obtained (or had even
applied for) registration before August 2 succeeded
August 1 in history. Nor is there any evidence that
defendants during the period between June 15, 1973,
and August 1, 1973, were ‘‘entitled to registration’’ per-
mitting them to handle phendimetrazine ©
THE DIRECTOR’S AUTHORITY IS ESTABLISHED BY 21
U.S.C. 871, 28 U.S.C. 510, Reorganization plan No. 2 of 1973 (28
U.S.C. 209, pocket part); and Section 0.100 of Title 18 CFR,
which provides:
$0.100 General Functions |
Subject to the general supervision of the Attorney General,
and under the direction of the Deputy Attorney general, the
following described matters are assigned to, and shall be
conducted, handled, or supervised by, the Administrator of
the Drug Enforcement Administration:
(a) Functions vested in the Attorney General by sections 1
and 2 of Reorganization Plan No. 1 of 1968.
(b) Functions vested in the Attorney General by the
Comprehensive Drug Abuse Prevention and Control Act of
1970.
(c) Functions vested in the Attorney General by section 1 of
Reorganization Plan No. 2 of 1973 and not otherwise
specifically assigned.
5 See Rule 45 (a) FRCrP, and the common law rule that fractions of
a day are to be disregarded.
6 By the time of trial in 1974 the existence VEL NON of registra-
tion by August 1, 1973, should have been easy to prove.
24
Defendants contend that it was the burden of the
Government ot establish their non-entitlement as part of
the crime.
The Act of 1970 provides that a person distributing or
proposing to distribute a controlled substance must ob-
tain a registration, which authorized them to engage in
such activity. 21 U.S.C. 822. Knowingly and intention-
ally to distribute a controlled substance except as
authorized by the Act is made criminal by 21 U.S.C. 841
(a).
It is provided in 21 U.S.C. 885 (a) (1) that the Govern-
ment need not negative any statutory exemption or
exception in any indictment or in any trial, but that ‘‘the
burden of going forward with the evidence with respect
to any such exemption or exception shall be upon the
person claiming its benefit.’’
It will be noted that this is a purely procedural pre-
sumption. It places on the defendants (who are pre-
sumably most familar with and best able to demonstrate
their own qualifications and efforts to obtain registra-
tion) to go forward with the evidence. It does not estab-
lish any irrebuttable presumption, which might be re-
garded as a substantive rule of law like the ‘‘parol
evidence rule.’’
Hence this fully rebuttable and procedural presump-
tion is not subject to the due process condemnation of
the types of presumption involved in the cases on which
defendants rely: TOT v. U.S., 319 U.S. 463, 466-68
(1943); Leary v. U.S., 395 U.S. 6, 36-37 (1969). Cf.
Turner v.U.S., 396 U.S. 398, 408, 423 (1970). See also
‘The Irrebuttable Presumption Doctrine in the Supreme
Court’’, 87 Harv. L.R. (May, 1974) 1534-56.
Accordingly, defendants’ motions are overruled, and
they are directed to present themselves for sentence in
due course.
25
ORDER
AND NOW, this 27th day of February, 1975, upon
consideration of defendants’ motions in arrest of judg-
ment and for new trial, for the reasons set forth in the
foregoing opinion.
IT IS ORDERED that said motions be and they
hereby are denied and overruled, and defendants are
directed to present themselves in due course for
sentence.
/s/ Dumbauld
United States District Judge
Richard L. Thornburgh, Esq.
United States Attorney
Pittsburgh, Pa. 15219
Bertani, Myers & Makoski
Attorneys-at-Law
Union Trust Building
100 North Main Street
Greensburg, Pa. 15601
26
Pe
APPENDIX C
AMENDMENT V
CONSTITUTION OF THE UNITED STATES
‘‘No person shall***be deprived of life, liberty or
property without due process of law.’’
STATUTES
Comprehensive Drug Abuse and Control Act of 1970.
Title 21 U.S.C.
Sec. 822 (a)
(a) Every person who manufactures,
distributes, or dispenses ANY CON-
TROLLED SUBSTANCE or who pro-
poses to engage in the manufacture,
distribution, or dispensing of ANY
CONTROLLED SUBSTANCE, shall
obtain annually a registration issued
by the Attorney General in accord-
ance with the rules and regulations
promulgated by him. (emphasis
added).
Sec. 841 (a) (1)
(a) EXCEPT as authorized by this title, it
shall be unlawful for any person
KNOWINGLY AND _ INTENTION-
ALLY
(1) to manufacture, distribute, or dis-
pense a CONTROLLED SUBSTANCE
(emphasis added).
27
Sec. 885
(a) (1) It shall NOT be necessary, for the
(b)
(a)
United States to negative any
exemption or exception set forth
in this subchapter in any com-
plaint, information, indictment, or
other pleading or IN ANY TRIAL,
hearing, or other proceeding un-
der this subchapter and the
BURDEN OF GOING FORWARD
WITH THE EVIDENCE WITH
RESPECT TO ANY SUCH EX-
EMPTION OR EXCEPTION
SHALL BE UPON THE PERSON
CLAIMING ITS BENEFIT.
IN THE ABSENCE OF PROOF THAT
A PERSON IS THE DULY AUTHOR-
IZED HOLDER OF AN APPROPR-
IATE REGISTRATION OR ORDER
FORM ISSUED UNDER THIS SUB-
CHAPTER, HE SHALL BE PRE-
SUMED NOT TO BE THE HOLDER
OF SUCH REGISTRATION OR
FORM, AND THE BURDEN OF
GOING FORWARD WITH THE
EVIDENCE WITH RESPECT TO
SUCH REGISTRATION OR FORM
SHALL BE UPON HIM. (emphasis
added)
Sec. 811 (a)
THE ATTORNEY GENERAL SHALL
APPLY the provisions of this sub-
chapter to the controlled substances
listed in the schedules established by
28
section 812 of this title and to any
other drug or other substance
ADDED to such schedules under this
subchapter. Except as provided in
subsection (d) and (e) of this section,
THE ATTORNEY GENERAL MAY
BY RULE --
(1) ADD TO SUCH A SCHEDULE or
transfer between such _ schedules
ANY DRUG OR SUBSTANCE IF
HE-.-
(A_ find that such drug or other sub-
stance has a potential for abuse, and
(B_ makes with respect to such drug
or other substance the findings pre-
scribed by subsection (b) of section
812 of this title for the schedule in
which such drug is to be placed; or
(2) remove any drug or other sub-
stance form the schedule if he finds
that the drug or other substance
does not meet the requirements for
inclusion in any schedule.
Rules of the Attorney General under this
subsection shall be made on the record
after opportunity for a hearing pursuant
to the rulemaking procedures prescribed
by subchapter II of chapter 5 of Title S.
Proceedings for the issuance, amend-
ment, or repeal of such rules may be
initiated by the Attorney General (1) on
his own motion, (2) at the request of the
Secretary, or (3) on the petition of any
interested party. (emphasis added)
29
es SE Ea
Sec. 871 metrizine, or who proposes to engage
(a) The Attorney General may delegate in the manufacture, distribution, dis-
any of his functions under this sub- pensing, importation, or exportation
chapter to any officer or empioyee of | of any of those substances, shall
Department of Justice. obtain a registration to conduct that
Reorganization Plan No. 1 of 1968 activity on or before August 1, 1973.
Title 28 U.S.C. (emphasis supplied)
8. CRIMINAL LIABILITY - Any activity
Sec. 510
The Attorney General may from time
to time make such provisions as he
considers appropriate authorizing the
performance by any officer, employee
or agency of the Department of
Justice of any function of the At-
torney General.
The Federal Register Volume 28, No. 115
Sec. 1, 8,9
with benzphetamine, chlorphenter-
mine, clortermine, fenfluramine,
mazindol, and phendimetrizine, not
authorized by, or in violation of the
Controlled Substances Act or the
Controlled Substances Import and
Export Act, conducted after June 15,
1973, shall be unlawful, except that
any person who is not now registered
to handle these substances but who is
entitled to registration under those
acts may continue to conduct normal
The requirements imposed upon the
a pmo baa nd om those substances between the date
order shall become effective as folows: on which this order is published and
1. REGISTRATION - Unless currently the date on which he obtains the
business or professional practice with
registered to conduct that activity
with Schedule III (or in the case of
fenfluramine, Schedule IV) non-nar-
cotic substances, or unless exempted
from registration by law, or pursuant
to 301.24 - 301.28 or 311.24 - 311.28
of Title 21 of the Code of Federal
Regulations, anv person who manu-
factures, distrioutes, dispenses, im-
ports, or exports benzphetamine,
chlorphentermine, clortermine, fen-
fluramine, mazindel, and phendi-
30
proper registration.
. OTHER - In all other respects, this
order is effective on June 15, 1973.
Dated June 12, 1973.
31
This is a copy of a public record, reproduced as it was published. It is not legal advice, and it may not be the version a court would rely on. Check the official source before you cite it.